San Antonio-Bluegrass Vascular Technologies has started to enroll patients in a U.S. clinical trial for its catheter system for regaining access to obstructed veins.
Bluegrass says it eventually will study 30 patients at 10 research centers across the U.S. in the next year, including St. Joseph Hospital in Orange, CA, and Houston Methodist Hospital in Texas. The company can file for FDA approval after it collects the data from the trial, says president and CEO Gabriele Niederauer.
Bluegrass, founded in 2010, received regulatory clearance in Europe in 2016 and started selling its system, called the Surfacer Inside-Out Access Catheter System,… Read more »
UNDERWRITERS AND PARTNERS